2 followers
Driven by its proprietary Enhanced Delivery Oligonucleotide (EDO) platform, PepGen is creating a pipeline of disease-modifying therapeutics with the potential to safely and effectively target the root cause of serious genetic diseases, with an initial focus on neuromuscular diseases.
James McArthur
Calico
6 followers
Tessera Therapeutics
2 followers
Kyverna Therapeutics
7 followers
Ventyx Biosciences
1 follower
Longeveron
1 follower
Astria Therapeutics
1 follower
Thermo Fisher Scientific
179 followers
Genentech
161 followers
Gilead Sciences
136 followers
Regeneron
104 followers
Vertex Pharmaceuticals
66 followers
Explore companies